Skip to main content

Table 1 Number of patients included in GIPAP by country in 2010

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

Countries Patients (N = 4,946) %
Albania 84 1.7%
Armenia 167 3.4%
Azerbaijan 256 5.2%
Barbados 3 0.1%
Belarus 26 0.5%
Benin 19 0.4%
Bhutan 6 0.1%
Burkina Faso 20 0.4%
Cambodia 32 0.6%
Cameroon 53 1.1%
Côte d'Ivoire 52 1.1%
Ethiopia 279 5.6%
Fiji 15 0.3%
Gabon 9 0.2%
Georgia 252 5.1%
Ghana 69 1.4%
Haïti 8 0.2%
Kazakhstan 164 3.3%
Kenya 355 7.2%
Kyrgyzstan 105 2.1%
Madagascar 27 0.5%
Mali 48 1.0%
Mauritius 22 0.4%
Moldova 72 1.5%
Mongolia 7 0.1%
Mozambique 2 0.0%
Nepal 540 10.9%
Niger 5 0.1%
Nigeria 331 6.7%
Republic of Congo 24 0.5%
Rwanda 12 0.2%
Saint Lucia 6 0.1%
Senegal 84 1.7%
Seychelles 7 0.1%
Sierra Leone 2 0.0%
Sudan 971 19.6%
Surinam 12 0.2%
Tajikistan 1 0.0%
Tanzania 51 1.0%
Togo 38 0.8%
Uganda 90 1.8%
Uzbekistan 560 11.3%
Zambia 27 0.5%
Zimbabwe 33 0.7%
\